Breaking News From Pharma & Bio Ingredients
Aurobindo Receives FDA OK for Zaleplon capsules
Posted on 2008-06-12 08:08:00
Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received the final approval from the US Food and Drug Administration (FDA) to manufacture and market Zaleplon capsules in 5mg and 10mg form. This is the company's 70th approval from the FDA.
Zaleplon capsules, the generic equivalent of King Pharmaceuticals' Sonata capsules, are indicated for the treatment of insomnia.
Aurobindo is in the first line of generics that got the FDA nod on the first day post the expiration of the relevant patent, and has already launched the product in the US market, the company stated in a press release, earlier this week
Subscribe via RSS
